| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Third Department of Internal Medicine, Osaka University School of Medicine, Osaka 553, Japan
Evidence is presented for the occurrence of an apparently identical alkaline phosphatase isozyme in sera and cancer tissues of different patients with hepatocellular carcinoma. The enzyme resembles the D-variant phenotype of the placental alkaline phosphatase in inhibition of amino acids including L-phenylalanine and L-leucine, ethylenediaminetetraacetate, and urea, and also in the molecular weight. However, it differs from it in heat stability, electrophoretic mobility, pH optimum and inhibition by phosphate. Immunochemically, the hepatoma-associated enzyme possesses antigenicity partially common to the placental isozyme.
These facts, in addition to its almost exclusive localization in hepatoma tissue, suggest that the enzyme is produced by the hepatoma.
1 This work was supported by Grants-in-aid from the Ministry of Education and the Ministry of Health and Welfare, Japan. The compendium of this article was presented at the Third International Conference on Isozymes held at Yale University, New Haven, Conn., April 17 to 20, 1974.
Received 6/19/74. Accepted 8/26/74.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |